What You Should Know:
– AstraZeneca has announced the acquisition of Icosavax, a biopharmaceutical company developing a promising vaccine targeting both RSV and hMPV, for a total of up to $1.1 billion.
– This acquisition strengthens…
Continue Reading
Sensitive emails, research data leaked from IIIT Delhi Cybersecurity platform CloudSEK reported that it spotted a data leak from the Portal for Health Informatics, the web portal for bioinformatics, health informatics, and genomics of the state…
Continue Reading
A partnership between the Coalition for Epidemic Preparedness Innovations (CEPI) and biotech company aVaxziPen, is hoping to improve access to vaccines by removing the need for frozen storage. CEPI will initially provide up to $1.6million…
Continue Reading
